The New Jersey Academy of Family Physicians is accepting poster abstracts for the NJAFP 2025 Annual Meeting. This is your opportunity to present a primary care clinical or research project to over 150 family physicians. Posters will be judged by an expert panel and awarded monetary prizes for first place in each of the categories below:

Research – Summarize the results of a well-defined basic or clinical research project. The submission should include:

• • Background/Introduction: A brief statement of the problem or research question, highlighting the significance and purpose of the study.
  • Objective/Purpose: A concise explanation of the main aim of the research or the hypothesis being tested.
  • Methods: A summary of the research design, methods, and techniques used to collect and analyze data, including sample size and key variables.
  • Results: A summary of the key findings of the research, including any significant outcomes or trends. Specific data or outcomes are usually presented here.
  • Conclusion: A brief statement on the implications of the findings, how they contribute to the field, and potential future research directions.

All work should be original. Projects may involve observational or interventional studies. Research which includes patients must have IRB approval.

Clinical Inquiry/Vignette – Present a clinical scenario that discusses either an actual patient case or reviews the current evidence-based recommendations for a clinical topic.

• • A clinical case presentation must include an introduction, a case description, a discussion of current practice guidelines for management of the patient, and a conclusion.
  • An evidence-based review need not be based on an actual patient case but must provide a systematic review of the current best evidence to answer a clinical question. The presentation should provide an evidence-based answer on a topic relevant to family medicine in everyday common practice and include an evidence summary, recommendations from others, clinical commentary, and a conclusion

Quality Improvement-Patient Safety – Submissions should report on efforts to enhance patient safety or measure patient outcomes. These efforts may include projects developed to promote patient safety or processes that have led to a safer environment for patients. Abstracts should include the following sections:

• • Background/Introduction: A brief overview of the patient safety issue or outcomes measurement challenge being addressed. This section should explain why the project or initiative was necessary.
  • Objective/Purpose: Clearly state the aim of the quality improvement project or patient safety initiative, such as improving a specific process or measuring and improving patient outcomes.
  • Methods: Describe the approach taken to improve patient safety or measure outcomes, including how data were collected and analyzed, and any tools or processes used to convert data into actionable information.
  • Results: Present key findings or improvements resulting from the project. Include any significant data or measurable outcomes that demonstrate the impact of the initiative on patient safety.
  • Conclusion: Summarize the outcomes of the project, discussing how the findings contribute to improved patient safety and any implications for future quality improvement efforts.

---

Poster Abstract Submission Instructions

Submission Guidelines

• The research must be of interest and educational value to family medicine and be conducted by an NJAFP early career Family Physician (within 16 years of graduating from medical school), a Family Medicine resident or a New Jersey medical student.
• Original work that has been completed in the past 2 years is eligible for submission.
• Works that have been published prior to the 2025 Annual Meeting are not eligible.
• All projects must be completed at the time of application.
• Entries may not be taken from previously published papers.
• Submissions must meet the requirements of the applicant's local institutional review board (approval or waiver), if applicable.
• Be prepared to provide a 50-word description of your poster. Do not cut/paste the entire abstract into this field. This is your poster “elevator speech.” Include title and all authors (does not count toward 50 words).

Abstract & Poster Guidelines

Abstracts are limited to 500 words and should include:

• Abstracts do not require references.
• Commercial product names are not permitted in poster content. Use only generic names of drugs and other products. The first use of the generic name on the poster may be marked by an asterisk with the brand name footnoted in type not exceeding 1/4 inch high. Give equal emphasis to all generic names of competitive products, ex: font height, weight, color, and/or typeface. Company logos may not be used in any part of the poster.
• If you disclosed financial support, you must include a credit line as a footnote in type not exceeding ¼ inch high. The footnote must read "Financial support for this poster was provided by (supporting company)."

Disclosure Requirements

All authors and co-authors must make a disclosure of conflict of interest. All financial relationships with any ineligible companies over the past 24 months must be disclosed. An ineligible company is a company whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. There is no minimum financial threshold; you must disclose all financial relationships, regardless of the amount, with ineligible companies

Any financial support must be indicated on the disclosure form. AAFP requires all authors to submit a disclosure form at the time of submission. Failure to disclose financial support will result in the submission being rejected or the poster being disqualified.

Submission Steps

1. Each author and co-author must submit a conflict-of-interest disclosure form HERE.
2. Once disclosure forms are submitted by all authors, the primary or secondary author submits the abstract HERE.

NOTE: The primary author is responsible for ensuring that all authors submit a disclosure form.

Abstract Submission Deadline

Your abstract and supporting material must be submitted by 11:59 PM on Friday, April 11^th, 2025. The online application will close at 12:00 AM on Tuesday, April 12^th, 2025.

Selection Criteria and Review Process

Selection for poster presentation at the 2025 Annual Meeting is based on the following criteria:

All categories

• • Value/Applicability to Family Medicine

Research and Quality Improvement

• • Project description
  • Objectives/purpose
  • Methodology
  • Presenters’ role in project
  • Results
  • Conclusions/discussion

Clinical Inquiry/Vignette 

• • Introduction
  • Case description
  • Discussion of practice guidelines
  • Conclusions/discussion

Poster Contest

If your abstract is accepted for poster presentation:

• The primary author will be notified of acceptance for presentation via email by Sunday, April 13^th, 2025
• All accepted poster presenters are required to register for the conference and pay the applicable registration fee. Please advise co-presenters of this policy. Registration information will be available soon.
• The first and/or second author must attend the 2025 Annual Meeting to:
  • Set up your poster by 6pm, Friday, May 2nd
  • Present your poster for judging on Saturday May 3^rd during the morning break and lunch:
    • Have your poster “elevator speech” ready and be prepared to answer questions from judges
    • The poster contest is eligible for CME credit so expect conference attendees during lunch
    • Remove your poster by 3pm Saturday (posters not removed will be discarded)

The poster should include the title of the presentation and the names of the authors. Lettering should be easily legible from about 3 feet. You are responsible for printing your poster. Your poster should fit on a 3’ x 4’ foam core board without too much overlap for viewing purposes. NJAFP will provide binder clips and a foam core board on an easel. Your poster should be prepared on heavyweight paper or lightweight cardboard, so it can be easily attached to the foam core or propped up on the easel.

Ethical Considerations

Poster content must be up-to-date and presented in an ethical manner. Comparisons of efficacy, contraindications, modes of administration, etc. between competitive products shall be fully presented. Editorial conclusions should be made with ethical restraint. If the poster deals with a pharmaceutical product, medical device or any product that is sold on the open market, the content of the poster must not be promotional. No application will be accepted if it is determined that the purpose, findings, and/or conclusions are promotional in nature. If applicable, please provide a copy of your letter of approval from your Institutional Review Board (IRB), confirming that you have designed your project so as to protect the rights and welfare of your research subjects.

Judging and Prizes

Posters will be judged on the following criteria:

• Originality
• Quality and clarity
• Organization
• Creativity of presentation
• Scientific merit
• Relevance to family medicine

The following prizes will be awarded for each category (early career physician, resident, student):

• First Place: $150
• Second Place: $100

Winners are announced at the new Awards Celebration on Saturday evening (additional registration and fee). You do not have to attend the Celebration to be awarded a prize.

 

Questions?

If you have any questions, please contact Tyger Haines at thaines@njafp.org

GOOD LUCK!!